Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 321-330 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
Karin Kohlstedt, Rudi Busse, and Ingrid Fleming
Hypertension 2005;45:126-132; published online before print as doi:10.1161/01.HYP.0000150159.48992.11 [Abstract] [Full text]  

Hypertension Highlights
Obesity-Associated Hypertension. New Insights Into Mechanisms
Kamal Rahmouni, Marcelo L.G. Correia, William G. Haynes, and Allyn L. Mark
Hypertension published December 6, 2004, doi:10.1161/01.HYP.0000151325.83008.b4 [Abstract]  

Brief Reviews
Hormone Replacement Therapy and Cardiovascular Disease: What Went Wrong and Where Do We Go From Here?
Raghvendra K. Dubey, Bruno Imthurn, Lefteris C. Zacharia, and Edwin K. Jackson
Hypertension 2004;44:789-795; published online before print as doi:10.1161/01.HYP.0000145988.95551.28 [Abstract] [Full text]  

Scientific Contributions
Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats
Jiu-Chang Zhong, Dong-Yang Huang, Yan-Mei Yang, Yi-Fan Li, Ge-Fei Liu, Xu-Hong Song, and Kun Du
Hypertension 2004;44:907-912; published online before print as doi:10.1161/01.HYP.0000146400.57221.74 [Abstract] [Full text]  

Scientific Contributions
Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition
Nicholas L.M. Cruden, Keith A.A. Fox, Christopher A. Ludlam, Neil R. Johnston, and David E. Newby
Hypertension 2004;44:913-918; published online before print as doi:10.1161/01.HYP.0000146483.78994.56 [Abstract] [Full text]  

Scientific Contributions
Impairment of PI3-K/Akt Pathway Underlies Attenuated Endothelial Function in Aorta of Type 2 Diabetic Mouse Model
Tsuneo Kobayashi, Kumiko Taguchi, Takenouchi Yasuhiro, Takayuki Matsumoto, and Katsuo Kamata
Hypertension 2004;44:956-962; published online before print as doi:10.1161/01.HYP.0000147559.10261.a7 [Abstract] [Full text]  

Scientific Contributions
Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease
Duncan J. Campbell, Mark Woodward, John P. Chalmers, Samuel A. Colman, Alicia J. Jenkins, Bruce E. Kemp, Bruce C. Neal, Anushka Patel, and Stephen W. MacMahon
Hypertension published November 29, 2004, doi:10.1161/01.HYP.0000151103.02424.c3 [Abstract]  

Scientific Contributions
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
Karin Kohlstedt, Rudi Busse, and Ingrid Fleming
Hypertension published November 29, 2004, doi:10.1161/01.HYP.0000150159.48992.11 [Abstract]  

Scientific Contributions
Impairment of PI3-K/Akt Pathway Underlies Attenuated Endothelial Function in Aorta of Type 2 Diabetic Mouse Model
Tsuneo Kobayashi, Kumiko Taguchi, Takenouchi Yasuhiro, Takayuki Matsumoto, and Katsuo Kamata
Hypertension published October 25, 2004, doi:10.1161/01.HYP.0000147559.10261.a7 [Abstract]  

Scientific Contributions
Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition
Nicholas L.M. Cruden, Keith A.A. Fox, Christopher A. Ludlam, Neil R. Johnston, and David E. Newby
Hypertension published October 18, 2004, doi:10.1161/01.HYP.0000146483.78994.56 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment